False extended-spectrum β-lactamase phenotype in clinical isolates of escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2006-2010

  Beceiro, Alejandro ^a,b,c   Maharjan, Sunil ^a   Gaulton, Tom ^a   Doumith, Michel ^a   Soares, Nelson C ^b   Dhanji, Hiran ^a   Warner, Marina ^a   Doyle, Maeve ^d   Hickey, Mary ^d   Downie, Gordon ^e   Bou, Germán ^b   Livermore, David M ^a   Woodford, Neil ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d WATERFORD REGIONAL HOSPITAL   (Ireland)

^e CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

lactam resistance; Cefepimases; Cefpiromases; ESBLs; Mutator phenotype

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE OXA 1; BETA LACTAMASE TEM 1; CEFEPIME; CEFEPIME PLUS CLAVULANIC ACID; CEFOTAXIME; CEFOTAXIME PLUS CLAVULANIC ACID; CEFOXITIN; CEFPIROME; CEFPIROME PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFTAZIDIME PLUS CLAVULANIC ACID; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; PENICILLINASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PORIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; GENE SEQUENCE; ISOELECTRIC FOCUSING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; CEPHALOSPORINS; CLAVULANIC ACID; DNA; DNA, RECOMBINANT; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ISOELECTRIC FOCUSING; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PORINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFORMATION, BACTERIAL;

EID: 80051682076     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr265     Document Type: Article

References (11)

1. Martínez-Martínez L. Extended-spectrum b-lactamases and the permeability barrier. Clin Microbiol Infect 2008; 14 Suppl 1: 82-9.
2. BSAC. BSAC Methods for Antimicrobial Susceptibility Testing (Version 9.1), March 2010. http://www.bsac.org.uk/
3. Bohnert JA, Karamian B, Nikaido H. Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother 2010; 54: 3770-5.
4. Rasheed JK, Jay C, Metchock B et al. Evolution of extended-spectrum b-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997; 41: 647-53.
5. Hornsey M, Ellington MJ, Doumith M et al. Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment. Int J Antimicrob Agents 2010; 35: 478-81.
6. Soares NC, Cabral MP, Gayoso C et al. Associating growth-phase-related changes in the proteome of Acinetobacter baumannii with increased resistance to oxidative stress. J Proteome Res 2010; 9: 1951-64.
7. Ellington MJ, Livermore DM, Pitt TL et al. Mutators among CTX-M b-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance. J Antimicrob Chemother 2006; 58: 848-52.
8. Lartigue MF, Leflon-Guibout V, Poirel L et al. Promoters P3, Pa/Pb, P4, and P5 upstream from blaTEM genes and their relationship to β-lactam resistance. Antimicrob Agents Chemother 2002; 46: 4035-7.
9. Aubert D, Poirel L, Chevalier J et al. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001; 45: 1615-20.
10. Miller K, O'Neill AJ, Chopra I. Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections. Antimicrob Agents Chemother 2004; 48: 23-9.
11. Hiraoka M, Okamoto R, Inoue M et al. Effects of β-lactamases and omp mutation on susceptibility to β-lactam antibiotics in Escherichia coli. Antimicrob Agents Chemother 1989; 33: 382-6.